Russell Hirsch – Startup Investor Profile

Dr. Russell Hirsch is a Managing Director at Prospect Venture Partners, specializing in biotechnology and medical device investments. He co-founded dedicated life science funds with over $1 billion in capital under management. Russell has a strong track record in the industry, previously holding positions at Mayfield and the University of California San Francisco. His investments include Aveo Pharmaceuticals, Intuitive Surgical Devices, and others. Prospect Venture Partners typically focuses on life science investments, particularly in biotechnology and medical devices. They prefer early to mid-stage startups and have a geographical preference for North America. The check size for investments at Prospect Venture Partners can vary based on the fund, with the latest fund closing at $500 million. Russell’s partnership and collaboration styles emphasize strategic support for portfolio companies.

Location:

Country: United States of America

Investment Regions:

Investment Stages: pre-seed, seed

Website:

AI Reasoning: Search results show Prospect Venture Partners’ recent visible investments date back to 2016 (SentreHEART) and earlier (NGM Biopharmaceuticals 2015). A cited portfolio investment includes NGM Biopharmaceuticals. No evidence of investments by Russell Hirsch or Prospect Venture Partners in the last several years (within past 12 months). Therefore classify as low-active (last known investment occurred more than 12 months ago).

Low Activity – Only known angel investments more than 12 months ago.

Active – Known angel investments between the last 12 and 6 months.

Very Active – Known angel investments in the last 6 months.